Hoang et al., 2020 - Google Patents

Epigenome-wide association study of DNA methylation and adult asthma in the Agricultural Lung Health Study

Hoang et al., 2020

View HTML @Free from Publisher
Document ID
5266672251223104424
Author
Hoang T
Sikdar S
Xu C
Lee M
Cardwell J
Forno E
Imboden M
Jeong A
Madore A
Qi C
Wang T
Bennett B
Ward J
Parks C
Beane-Freeman L
King D
Motsinger-Reif A
Umbach D
Wyss A
Schwartz D
Celedón J
Laprise C
Ober C
Probst-Hensch N
Yang I
Koppelman G
London S
Publication year
Publication venue
European Respiratory Journal

External Links

Continue reading at erj.ersjournals.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment; Prognosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology

Similar Documents

Publication Publication Date Title
Hoang et al. Epigenome-wide association study of DNA methylation and adult asthma in the Agricultural Lung Health Study
Mukherjee et al. Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
Smolonska et al. Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis
Vijverberg et al. Biomarkers of therapy responsiveness in asthma: pitfalls and promises
Murphy et al. Methylomic markers of persistent childhood asthma: a longitudinal study of asthma-discordant monozygotic twins
Yan et al. Exposure to violence, chronic stress, nasal DNA methylation, and atopic asthma in children
Legaki et al. DNA methylation biomarkers in asthma and rhinitis: are we there yet?
Tsai et al. Neutrophil extracellular trap production and CCL4L2 expression influence corticosteroid response in asthma
Himes et al. ITGB5 and AGFG1 variants are associated with severity of airway responsiveness
Lin et al. Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
Dobbyn et al. Co-localization of Conditional eQTL and GWAS Signatures in Schizophrenia
Han et al. Large-scale genetic analysis identifies 66 novel loci for asthma
Gereige et al. A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts
Grammer et al. A comprehensive approach to identify approved drugs and treatments for repositioning as therapies for systemic lupus erythematosus
Zapantis et al. Eculizumab in recalcitrant antiphospholipid antibody syndrome
Cardinale et al. Genetic Underpinnings of Asthma and Related Traits
Minkin et al. Smoking and secondhand smoke among patients with systemic lupus erythematosus and controls: associations with disease and disease damage
Kan et al. Cluster analysis of longitudinal treatment patterns in patients newly diagnosed with systemic lupus erythematosus in the United States
Peschken et al. High mortality in North American Natives with systemic lupus erythematosus
Doerner et al. Elucidating the role of TNF-like weak inducer of apoptosis in the pathogenesis of cutaneous lupus
Olsen et al. Is prevention of systemic lupus erythematosus a goal?
Ghoreishi et al. A role for cutaneous gamma delta T cells in the development of systemic lupus erythematosus
Shao et al. Aggregation of MAVS antiviral protein suggests a mechanism for increased type I interferon production in SLE
Forbess et al. Outcome measures in systemic lupus erythematosus: constructing a meaningful response index from existing clinical trial data
Feldman et al. Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006